PHASE II PILOT STUDYOF VELCADE® (BORTEZOMIB) IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Kong, Xiao-Tang [1 ]
Green, Stacey [1 ]
Filka, Emese [1 ]
Green, Richard [2 ]
Yong, William [1 ]
Nghiemphu, Phioanh [1 ]
Cloughesy, Timothy [1 ]
Lai, Albert [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Kaiser Permanente Los Angeles, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [31] Phase Ib study of cediranib in combination with daily temozolomide and radiation in patients with newly diagnosed glioblastoma
    Chi, A. S.
    Gerstner, E. R.
    Eichler, A. F.
    Chea, H. K.
    Drappatz, J.
    Wen, P. Y.
    Ivy, S. P.
    Loeffler, J. S.
    Sorensen, A. G.
    Jain, R. K.
    Batchelor, T. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] A phase II trial of radiation plus temozolomide followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma multiforme (NABTT #0501)
    Rosenfeld, M. R.
    Chamberlain, M. C.
    Grossman, S. A.
    Peereboom, D. M.
    Lesser, G. J.
    Batchelor, T. T.
    Desideri, S.
    Salazar, A. M.
    Ye, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Vredenburgh, James J.
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Kirkpatrick, John P.
    Herndon, James E., II
    Coan, April D.
    Bailey, Leighann
    Janney, Dorothea
    Lu, Cynthia
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2011, 13 : 89 - 90
  • [34] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
    Aherne, Noel J.
    Benjamin, Linus C.
    Horsley, Patrick J.
    Silva, Thomaz
    Wilcox, Shea
    Amalaseelan, Julan
    Dwyer, Patrick
    Tahir, Abdul M. R.
    Hill, Jacques
    Last, Andrew
    Hansen, Carmen
    McLachlan, Craig S.
    Lee, Yvonne L.
    Mckay, Michael J.
    Shakespeare, Thomas P.
    NEUROLOGY RESEARCH INTERNATIONAL, 2014, 2014
  • [36] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Marc
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Piantadosi, Steven
    Fisher, Joy
    Fine, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
  • [37] Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme
    Barrié, M
    Couprie, C
    Dufour, H
    Figarella-Branger, D
    Muracciole, X
    Hoang-Xuan, K
    Braguer, D
    Martin, PM
    Peragut, JC
    Grisoli, F
    Chinot, O
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1177 - 1184
  • [38] KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Bahng, Hye Hyun
    Green, Stacey
    Lai, Albert
    Hu, Jethro
    Green, Richard
    Iwamoto, Fabio
    Lassman, Andrew B.
    Cloughesy, Timothy
    Nghiemphu, Phioanh
    NEURO-ONCOLOGY, 2017, 19 : 20 - 20
  • [39] Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
    Chinot, OL
    Barrie, M
    Frauger, E
    Dufour, H
    Figarella-Branger, D
    Palmari, J
    Braguer, D
    Hoang-Xuan, K
    Moktari, K
    Peragut, JCC
    Martin, PMM
    Grisoli, F
    CANCER, 2004, 100 (10) : 2208 - 2214
  • [40] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Nghiemphu, Phioanh Leia
    Wen, Patrick Y.
    Lamborn, Kathleen R.
    Drappatz, Jan
    Robins, H. Ian
    Fink, Karen
    Malkin, Mark G.
    Lieberman, Frank S.
    DeAngelis, Lisa M.
    Torres-Trejo, Alejandro
    Chang, Susan M.
    Abrey, Lauren
    Fine, Howard A.
    Demopoulos, Alexis
    Lassman, Andrew B.
    Kesari, Santosh
    Mehta, Minesh P.
    Prados, Michael D.
    Cloughesy, Timothy F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427
12345